10x Genomics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
10x Genomics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2023.
  • 10x Genomics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $33.9M, a 15.7% decline year-over-year.
  • 10x Genomics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $147M, a 12.8% decline year-over-year.
  • 10x Genomics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $167M, a 22% increase from 2022.
  • 10x Genomics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $137M, a 42.6% increase from 2021.
  • 10x Genomics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $96M, a 97.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $167M +$30.1M +22% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $137M +$40.9M +42.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $96M +$47.3M +97.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $48.6M +$35.3M +265% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 $13.3M +$10.7M +402% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 $2.66M +$997K +60% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $1.66M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.